Abstract
Neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis and polyglutamine diseases are caused by aggregation and abnormal accumulation of the disease-causative proteins in brain and spinal cord. Recent studies have suggested that proteins associated with neurodegenerative diseases are secreted and transmitted intercellularly via extracellular vesicles (EVs), which may be involved in propagation of abnormal protein accumulation and progressive degeneration in patient brains. On the other hand, it has been also reported that EVs have neuroprotective roles in these diseases, which potentially contribute to preventing aggregation formation and aberrant accumulation of the disease-associated proteins. In this review, I summarize the current understanding of the roles of EVs in neurodegenerative diseases, especially focussing on the pathogenic and neuroprotective aspects. Elucidation of these two aspects of EVs would provide insight into not only potential therapeutic targets for treatment of neurodegenerative diseases but also development of EV-based biomarkers for disease diagnostics
Funding Information
  • Aid for Scientific Research for Japan Society for the Promotion of Science
  • Young Scientists (A) and for Scientific Research (B) from the JSPS (11J08829, 26713030, 18H02585)
  • Precursory Research for Embryonic Science and Technology (PRESTO) of the Japan Science and Technology Agency (JPMJPR17H8)
  • Asahi Glass Foundation, Mochida Memorial Foundation, Nakatani Foundation
  • Nakatomi Foundation
  • Tokyo Biochemical Research Foundation and the Uehara Memorial Foundation

This publication has 41 references indexed in Scilit: